Esophageal Stricture Caused by ALK-Positive NSCLC Esophageal Metastasis Resolved After a Few Days of Lorlatinib Therapy Without Stent Placement

• Vito Longo, MD, PhD,
• Annamaria Catino, MD,
• Michele Montrone, MD, PhD,
• Pamela Pizzutilo, MD,
• Ippazio Ugenti, MD,
• Rosanna Lacalamita, PhD,
• Gabriella Del Bene, MD,
• Francesco Pesola, MD,
• Ilaria Marech, MD,
• Domenico Galetta, MD

Affiliations

Vito Longo, MD, PhD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy; Corresponding author. Address for correspondence: Vito Longo, MD, PhD, Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Viale Orazio Flacco 65, Bari 70124, Italy.

Annamaria Catino, MD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Michele Montrone, MD, PhD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Pamela Pizzutilo, MD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Ippazio Ugenti, MD

Digestive Endoscopy Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Rosanna Lacalamita, PhD

Molecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Gabriella Del Bene, MD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Francesco Pesola, MD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Ilaria Marech, MD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy

Domenico Galetta, MD

Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II,” Bari, Italy